Patient Level Delay in Diagnosis of Multi-Drug Resistant Tuberculosis among Patients Attending Tertiary Care Hospital in Haryana
Abstract
Background: Multi-Drug Resistant Tuberculosis (MDR-TB) besides increasing cost and duration of treatment also increases the mortality and morbidity. Less awareness in the community and diagnostic constraints for MDR-TB at patient level is a major cause of delay in diagnosis.
Objective: To find out the delay in diagnosis of MDR-TB and factors affecting this delay among MDR-TB patients attending tertiary care hospital, PGIMS Rohtak, Haryana, India.
Material and Methods: It is a hospital based cross-sectional study carried out in the department of Respiratory Medicine, PGIMS Rohtak, Haryana from March 2018 to February 2019 among 125 admitted patients of MDR-TB in tertiary care hospital, PGIMS Rohtak. A pre-designed, pre-tested, semi-structured interview schedule was used and data were analysed using SPSS version 20.0 and Chi square test was applied.
Result: The mean and median patient delay was found to be 31.11 days and 21 days, respectively. Extent of patient delay was significantly associated with socio-demographic factors like age, sex, literacy status, occupation, addiction and past history of TB in patients.
Conclusion: In this study, it was concluded that there was significant delay in the diagnosis as well as seeking treatment at patient level which was associated with socio-demographic factors. Thus, there is urgent need to boost up the Information, Education and Communication (IEC) activities to increase awareness among general public about the importance of early diagnosis and treatment of MDR-TB.
How to cite this article:
Jain RB, Gupta R, Sharma S, Kumar T, Agrawal G, Choudhary P et al. Patient Level Delay in Diagnosis of Multi-Drug Resistant Tuberculosis among Patients Attending Tertiary Care Hospital in Haryana. Epidem Int 2019; 4(4): 8-15.
DOI: https://doi.org/10.24321/2455.7048.201918
References
World Health Organization. Global TB Report 2019. World Health Organization. 2019; 1–277. Available
from: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf?ua=1.
Centre for disease control and prevention. TB Elimination (Multidrug-Resistant TB (MDR TB)). Atlanta.
Centre for disease control and prevention. 2012; 1-2.
World Health Organization. Multidrug-Resistance TB (MDR-TB): 2017 Update. Geneva. World Health
Organization; 2017. Available from: https://www.who.int/tb/challenges/mdr/MDR-RR_TB_factsheet_2017.
pdf.
Alavi SM, Bakhtiyariniya P, Albagi A. Factors associated with delay in diagnosis and treatment of pulmonary
tuberculosis. Jundishapur J Microbiol 2015; 8(3): 8-11. [PubMed/ Google Scholar].
Li Y, Ehiri J, Tang S, Li D, Bian Y, Lin H et al. Factors associated with patient, and diagnostic delays in
Chinese TB patients: A systematic review and metaanalysis. BMC Med 2013; 11(1): Article number: 156.
Available from: https://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-11-156 [PubMed/
Google Scholar].
Li Y, Ehiri J, OrenE, HuD, Luo X, Liu Y etal. Are we doing enough to stem the tide of acquired MDR-TB
in countries with high TB burden? Results of a mixed method study in chongqing, china. PLoS One 2014;
(2): e88330. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0088330
[DOI: https://doi.org/10.1371/journal.pone.0088330/PubMed/ Google Scholar].
Htun YM, Khaing TMM, Yin Y, Myint Z, Aung ST, Hlaing TM et al. Delay in diagnosis and treatment among adult
multidrug resistant TB patients in Yangon Regional TB Center, Myanmar: A cross-sectional study. BMC
Health Serv Res 2018; 18(1): 878. Available from: https://bmchealthservres.biomedcentral.com/
articles/10.1186/s12913-018-3715-4 [PubMed/ Google Scholar].
Narasimooloo R, Ross A. Delay in commencing treatment for MDR TB at a specialized TB treatmentcenter in KwaZulu-Natal. S Afr Med J 2012; 102(6): 360-362. Available from: http://www.samj.org.za/
index.php/samj/article/view/5361/4127 [PubMed/ Google Scholar].
Zhang X, Yin J, Li H, Li S, Walley J, Zou G et al. Diagnostic and treatment delays of multidrug-resistant TB before
initiating treatment: a cross-sectional study. Trop Med Int Heal 2015; 20(11): 1431-1437. Available from:
https://onlinelibrary.wiley.com/doi/full/10.1111/tmi.12566 [PubMed/ Google Scholar].
Rifat M, Hall J, Oldmeadow C, Husain A, Milton AH. Health system delay in treatment of multidrug
resistant TB patients in Bangladesh. BMC Infect Dis [Internet] 2015 [cited 2019 April 25]; 15(1): 526.
Available from: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-015-1253-9 [PubMed/
Google Scholar].
